CARA THERAPEUTICS
Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation. Cara possesses both near-term clinical development opportunities combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's most advanced patented compound, CR845, is currently undergoing clinical testing for acute pain and pruritis. This best-in-class compound possesses unique analgesic and anti-inflammatory activities appropriate for multiple therapeutic applications. In addition, Cara aims to develop a future pipeline of first-in-class molecules at novel analgesic and anti-inflammatory targets using its proprietary drug screening technology.
CARA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2004-07-02
Address:
Shelton, Connecticut, United States
Country:
United States
Website Url:
http://www.caratherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
+1 203 567 1503
Email Addresses:
[email protected]
Total Funding:
472.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Devon Park BioVentures
Devon Park BioVentures investment in Series D - Cara Therapeutics
Mitsubishi Corporation
Mitsubishi Corporation investment in Series D - Cara Therapeutics
MVM Life Science Partners
MVM Life Science Partners investment in Series D - Cara Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series D - Cara Therapeutics
Scottish Widows Investment Partnership
Scottish Widows Investment Partnership investment in Series D - Cara Therapeutics
Ascent Biomedical Ventures
Ascent Biomedical Ventures investment in Series D - Cara Therapeutics
Alta Partners
Alta Partners investment in Series D - Cara Therapeutics
Rho Capital Partners
Rho Capital Partners investment in Series D - Cara Therapeutics
Connecticut Innovations
Connecticut Innovations investment in Series C - Cara Therapeutics
Devon Park BioVentures
Devon Park BioVentures investment in Series C - Cara Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-03 | Cara Therapeutics Announces CEO Transition |
Official Site Inspections
http://www.caratherapeutics.com Semrush global rank: 4.84 M Semrush visits lastest month: 1.85 K
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 3.33.130.190
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Cara Therapeutics"
Cara Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number +1 203 567 1503 Cara Therapeutics is an emerging biotechnology company focused on developing …See details»
Investor Relations | Tvardi Therapeutics
Apr 14, 2025 Investor Relations. Tvardi Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 …See details»
INSPIRING NEW TREATMENTS - caratherapeutics.com
& Head of Investor Relations, at [email protected]. Overview Governance Environmental Social Responsibility The Future: 2023 Environmental, Social, Governance …See details»
Cara Therapeutics, Inc. - BioCT
BioCT 101 College Street New Haven, CT 06510 [email protected]. BioCT Innovation Commons 93 Shennecossett Road Groton, CT 06340 [email protected]See details»
Cara Therapeutics Company Profile | Management and Employees …
Www.caratherapeutics.com Cara Therapeutics Profile and History Cara Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical …See details»
cara - Cara Therapeutics, Inc. | Company Profile | OTC Markets
Mar 13, 2025 www.caratherapeutics.com (203) 406-3700. Business Description. Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing …See details»
Cara Therapeutics, Inc. Company Profile - Dun & Bradstreet
Company Description: Cara Therapeutics is a development-stage biopharmaceutical company driving innovation in sizable, yet underserved diseases and conditions. Its primary activities to …See details»
Cara Therapeutics - Craft
Oct 29, 2024 Cara Therapeutics has 5 employees at their 1 location and $7.14 m in annual revenue in FY 2024. See insights on Cara Therapeutics including office locations, competitors, …See details»
Cara Therapeutics (CARA) Company Profile & Description - Stock …
Jan 31, 2014 Ticker Symbol: CARA: Exchange: NASDAQ: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: CIK Code: 0001346830: CUSIP …See details»
Cara Therapeutics - LifeScienceHistory.com
Www.caratherapeutics.com. 400 Atlantic Street, Suite 500. Stamford, CT 6901. Company Info Phone (203) 406-3700 Year Established 2004 Ticker CARA Exchange NASDAQ. Contacts …See details»
Board of Directors - Cara Therapeutics
Board of Directors - Cara TherapeuticsSee details»
Cara Therapeutics and Tvardi Therapeutics Announce Entry into …
Dec 18, 2024 Management and Organization. Following the Merger, the combined company will be headquartered in Houston, Texas, and will be led by Tvardi’s CEO, Imran Alibhai, Ph.D., …See details»
CARA Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.caratherapeutics.com. Public Company | Subsidiary Company | 2004 | Connecticut, United States | 50-100 | NASDAQ: CARA | www.caratherapeutics.com. Last update 20 Apr 2025. …See details»
Cara Therapeutics CEO and Key Executive Team | Craft.co
Cara Therapeutics's Chairman is Martin Vogelbaum. Other executives include Ryan Maynard, Chief Financial Officer; Jeffrey L. Ives, Director and 9 others. See the full leadership team at …See details»
Cara Therapeutics Inc Company Profile - Overview - GlobalData
Website www.caratherapeutics.com Telephone 1 203 4063700. No of Employees 55. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange CARA (NASD) Revenue (2023) …See details»
Cara Therapeutics - VentureRadar
"Cara Therapeutics is an emerging biotechnology company focused on developing novel therapeutics to treat human diseases associated with pain and inflammation.See details»
Cara Therapeutics Prioritizes Late-Stage Notalgia Paresthetica …
Jan 22, 2024 Mr. Posner continued, “Unfortunately, as a result of the difficult decision to restructure the Company, many of our talented team members will depart the organization.See details»
Cara Therapeutics Company Description - Stock Analysis
Jan 22, 2025 Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the …See details»
Cara Therapeutics, Inc. - Cruelty Free Investing
CARA Therapeutics, Inc. is a clinical-stage company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes opioid …See details»
Cara Therapeutics - Overview, News & Similar companies
May 17, 2024 Cara Therapeutics contact info: Phone number: (203) 406-3700 Website: www.caratherapeutics.com What does Cara Therapeutics do? Cara Therapeutics is a clinical …See details»